Yan Yin

600 total citations
39 papers, 468 citations indexed

About

Yan Yin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yan Yin has authored 39 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Yan Yin's work include Lung Cancer Treatments and Mutations (7 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Yan Yin is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Yan Yin collaborates with scholars based in China, United States and Saudi Arabia. Yan Yin's co-authors include Yushang Cui, Lina Long, Xue Hu, Lei Cao, Xiaohui Xu, Ye Zhang, Yongli Chen, Hua Jiang, Hongwei Dai and Rui Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Yan Yin

38 papers receiving 465 citations

Peers

Yan Yin
Comparison fields: 5 of 94
  • Molecular Biology 237
  • Cancer Research 166
  • Surgery 63
  • Immunology 51
  • Pulmonary and Respiratory Medicine 49
Replace Lili Lin with:
Lili Lin China
Chenchen Xu China
Qian Nie China
Xiaoxia Huang China
Stijn Moens Belgium
Huayi Lü China
Tianlin Xiao China
Jingyi Guo China
Jinmiao Li China
Lili Lin China View profile →
Citations per field, relative to Yan Yin
Yan Yin · 1×
Citations per year, relative to Yan Yin
Yan Yin · 1×

Countries citing papers authored by Yan Yin

Since Specialization
Citations

This map shows the geographic impact of Yan Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Yin more than expected).

Fields of papers citing papers by Yan Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Yin. The network helps show where Yan Yin may publish in the future.

Co-authorship network of co-authors of Yan Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Yin. A scholar is included among the top collaborators of Yan Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Yin. Yan Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 2
3 3
4 3
5 5
6 1
7 5
8 9
9 53
10 3
11 9
12 20
13 26
14 6
15 9
16 2
17 5
18
A novel MYOC heterozygous mutation identified in a Chinese Uygur pedigree with primary open-angle glaucoma.
7
19 15
20 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026